Coordinated efforts to harmonise gynaecological cancer care.

Abstract

Gynaecological cancers are among the most prevalent cancers in women worldwide. The types of cancers included in this group include cervical cancer, elimination of which has become a global goal in cancer control over the past two decades due to effective human papillomavirus (HPV) vaccination and screening programmes, and ovarian cancer, which still generally presents at a late stage due to a lack of effective screening tests and for which outcomes can be poor. In view of the prevalence of these cancers and the substantial burden these diseases have on women around the world, coordinated efforts are still very much needed to optimise treatment of women's cancers. In this issue of The Lancet Oncology, we publish a Series of two papers related to gynaecological cancers. In the first paper, Ignace Vergote and colleagues present the consensus recommendations from the sixth Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research. In the second paper, Maria Kyrgiou and colleagues present the 2022 consensus recommendations on the terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer, in a concerted effort from the European Society of Gynaecologic Oncology, the European Federation for Colposcopy, the International Federation of Cervical Pathology and Colposcopy, and the European Society of Pathology.